Adult ADHD symptoms: how ADHD shows up in adults, assessment and treatment

ADHD (attention-deficit/hyperactivity disorder) is a persistent pattern of inattention and/or hyperactivity and impulsivity that makes it hard to function in several areas of life, such as home, school or work. By definition, symptoms must begin in childhood, but many adults also have ADHD (NIMH, 2024).

Everyone loses focus or misplaces things now and then. The International Classification of Diseases (ICD-11) points out that such symptoms are present in many children, adolescents and adults, and that ADHD requires them to be persistent over time, pervasive across situations, clearly out of keeping with developmental level and directly harmful to study, work or relationships (WHO, 2024).

mind.io does not offer an ADHD test. This guide uses research and official sources to set out how ADHD shows up in adults, what else can look like it, and how assessment and treatment actually work. In Korea, adult ADHD is diagnosed in an interview with a psychiatrist (National Mental Health Information Portal, 2020).

On the attention side, adults may find it hard to stay focused on tasks that are not very stimulating or rewarding, miss details and make careless mistakes, and leave tasks unfinished. They are easily distracted by other thoughts or stimuli, often lose things or forget daily tasks, and find it hard to plan and organise (WHO, 2024). The US National Institute of Mental Health (NIMH) lists disorganisation and procrastination, poor time management and trouble focusing on a large task among adult symptoms (NIMH, 2024). Inattention may not show, though, during activities that are intensely stimulating and frequently rewarding (WHO, 2024).

Hyperactivity becomes less visible with age. Rather than running about as in childhood, adults may feel physically restless and uncomfortable being quiet or sitting still. Impulsivity can show as interrupting or intruding, trouble waiting one’s turn, decisions made without weighing risks or consequences, and reckless driving. These symptoms can make it hard for adults to hold down a job or keep close relationships going (WHO, 2024).

Some features are common without being diagnostic criteria. ICD-11 lists emotional dysregulation and low frustration tolerance as common in ADHD (WHO, 2024). In a meta-analysis of 13 studies (2,535 people), adults diagnosed with ADHD showed much more difficulty regulating emotions than healthy controls (g = 1.17) (Beheshti et al., 2020). A meta-analysis of sleep studies found that, compared with healthy controls, they took longer to fall asleep and rated their own sleep quality lower (Lugo et al., 2020).

The US diagnostic criteria (DSM-5) require, from age 17, at least 5 symptoms in either the inattention or the hyperactivity-impulsivity domain (6 for those aged 16 or under) lasting at least 6 months, several symptoms present before age 12, symptoms in two or more settings (work, home, friends and so on) that clearly impair functioning, and no better explanation by another mental disorder (National Mental Health Information Portal, 2020; NIMH, 2024). This does not mean you must have been diagnosed before 12: some people first come for care as adults, when the demands of work and life exceed what they can compensate for (WHO, 2024).

ICD-11 sets no symptom count but likewise requires symptoms before age 12, symptoms across situations, and no better explanation by another cause. For adults it notes that a partner, family member or co-worker can add important information, and that without corroboration from childhood records or people who knew the person then, a diagnosis should be made with caution (WHO, 2024). Assessment may therefore include asking for school reports or talking with family (NIMH, 2024).

Whether ADHD can begin in adulthood is still debated. In a study that followed 1,037 people born in New Zealand to age 38, 90% of adult ADHD cases had no history of childhood ADHD, a finding the authors said needs replication (Moffitt et al., 2015). But in a study that repeatedly and thoroughly assessed 239 people without childhood ADHD up to an average age of 24, about 95% of those who first screened positive on symptom checklists were excluded from an ADHD diagnosis after full assessment; among those with impairing symptoms, the most common reason was that symptoms occurred only during heavy substance use (Sibley et al., 2018). The Korean national mental health portal also describes symptoms first appearing in adulthood as still open to debate (National Mental Health Information Portal, 2020).

Across 20 World Health Organization World Mental Health surveys of adults aged 18 to 44, an average of 2.8% met the criteria for ADHD (Fayyad et al., 2017). A meta-analysis of adult studies, adjusted to the 2020 world population, estimated 2.58% when onset in childhood was required; counting only current symptoms, without checking childhood onset, gave 6.76%, and such definitions yield higher figures than those requiring childhood onset. Both estimates fell with age; with childhood onset required, they ranged from 5.05% at ages 18 to 24 to 0.77% at 60 and over (Song et al., 2021).

It is neither true that ADHD simply goes away in adulthood nor that it mostly stays the same. In a meta-analysis of studies following people diagnosed with ADHD in childhood, about 15% still met the full criteria at 25, but about 65% did when partial remission, with some impairing symptoms remaining, was included (Faraone et al., 2006). In a study that followed 558 children with ADHD from a treatment study (MTA) to an average age of 25, 9.1% showed sustained recovery and 63.8% moved back and forth between better and worse periods (Sibley et al., 2022). ICD-11 also notes that even as hyperactivity becomes less visible, inattention, impulsivity and restlessness can remain (WHO, 2024).

In Korea, the number of people receiving health-insurance care with ADHD (F90) as the main diagnosis, counted by claim-review year, rose from 77,996 in 2019 to 325,221 in 2025, and among people in their 20s from 12,425 to 82,997. In 2025, women outnumbered men among patients in their 20s and 30s (Health Insurance Review and Assessment Service, 2026). These are people treated, not prevalence. Analysing 2008-2018 data, researchers pointed to growing awareness of ADHD and of its persistence into adulthood as possible reasons for more adult diagnoses, and since September 2016 adults first diagnosed between 6 and 65 have also been covered by health insurance (Seo et al., 2022).

There are many reasons other than ADHD for trouble concentrating. ICD-11 notes that other mental disorders such as anxiety or depression, the effects of some medicines (for example bronchodilators or thyroid hormone) or substances and their withdrawal, and physical conditions such as low blood sugar, thyroid problems or sleep-wake disorders can cause ADHD-like symptoms and need to be told apart. Hyperactivity that starts abruptly in adulthood may signal bipolar or psychotic disorder (WHO, 2024); if that happens, see a psychiatrist without delay. Concentration problems in depression and anxiety are covered in depression symptoms and anxiety symptoms, and work-related concentration loss in burnout symptoms. Everyday forgetfulness from sleep, stress or age is covered in the forgetfulness guide. Common reasons for poor concentration, and what helps, are in the concentration guide. ADHD can also overlap with autism; ICD-11 explains that both can be diagnosed when the criteria for each are met (WHO, 2024). Autism is covered in autism in adults. Tic disorders also often occur with neurodevelopmental conditions such as ADHD (WHO, 2024); tics are covered in tics and Tourette syndrome.

Conversely, other difficulties often come with ADHD. In a US survey of adults aged 18 to 44 (2001 to 2003), among those estimated to have current ADHD, 47.1% had had an anxiety disorder in the past year, 38.3% a mood disorder and 15.2% a substance use disorder (Kessler et al., 2006). In Korean health-insurance data, 78.72% of adult ADHD patients also had at least one other psychiatric diagnosis, including depressive disorder in 45.76% and anxiety disorder in 23.80% (Seo et al., 2022). The Korean national mental health portal notes that adults who first come for care are often treated only for the depression or anxiety that comes with ADHD (National Mental Health Information Portal, 2020). Whether or not depression comes with it, if you have thoughts of harming yourself, do not carry them alone: call or text 988 now in the US or Canada, call Samaritans on 116 123 in the UK or Ireland, or find a line at findahelpline.com elsewhere.

“Isn’t everyone a little ADHD?” In a study of children’s data, ADHD traits looked more like a matter of degree that varies from person to person than something you either have or do not (Marcus & Barry, 2011). A diagnosis, however, requires symptoms that are persistent, appear across situations, are clearly out of keeping with developmental level and directly get in the way of life (WHO, 2024).

“Too much screen time causes ADHD” is not an established fact either. In a study that followed adolescents, digital media use had a statistically significant but modest association with later ADHD symptoms, and the researchers said more research was needed to tell whether it is causal (Ra et al., 2018).

ADHD information on social media also deserves caution. In a study of the 100 most popular English-language ADHD videos on TikTok in 2021, 52 were misleading (Yeung et al., 2022). Recognising yourself in many items of a list in a video does not mean you have ADHD.

ADHD can only be diagnosed by a qualified clinician who interviews the person and/or family to document the criteria; it cannot be diagnosed by rating scales, neuropsychological tests or brain imaging alone (Faraone et al., 2021). The UK’s National Institute for Health and Care Excellence (NICE) also advises against diagnosing on rating scales or observation alone (NICE, 2018). In Korea, the diagnosis is made in an interview with a psychiatrist (National Mental Health Information Portal, 2020).

Clinics and studies sometimes use screening questionnaires such as the World Health Organization Adult ADHD Self-Report Scale (ASRS) as an aid. In 154 US survey participants, sampled to include more people who reported childhood ADHD, the 6-question screener picked out 68.7% of clinically diagnosed cases, missing about 3 in 10 (Kessler et al., 2005). In a study comparing 51 adults with ADHD and 158 controls, the Korean screener picked out about 63% of the patients, while about 1 in 5 controls without ADHD also screened positive (Heo et al., 2018). And among 17,799 Korean adults who volunteered answers at national health check-ups, 81.4% of those who screened positive also screened positive for depression on the PHQ-9 (Woo et al., 2023). A positive screen is a reason to get assessed, not a diagnosis.

Treatment works. In a network meta-analysis of 113 randomised trials (14,887 adults diagnosed with ADHD), stimulants and atomoxetine were the only treatments that reduced core symptoms more than placebo over about 12 weeks on both self-rated and clinician-rated scales (certainty of evidence very low to moderate), though more people stopped atomoxetine than placebo. Cognitive behavioural therapy, mindfulness, psychoeducation and others beat placebo only on clinician ratings; medicines showed no benefit on other outcomes such as quality of life, and long-term effects remain under-studied (Ostinelli et al., 2025). A Cochrane review of cognitive behavioural therapy for adults likewise found low-quality evidence that it may help in the short term (Lopez et al., 2018). Which treatment suits you, and which medicines are available, is a decision to make with a psychiatrist. ADHD medicines are prescribed and used under a doctor’s supervision; do not take someone else’s or obtain them without a prescription.

Q. Can an adult ADHD self-test tell me if I have it? A. No checklist or screening questionnaire can (Faraone et al., 2021; NICE, 2018). In a study that thoroughly assessed people without childhood ADHD, about 95% of people who screened positive on symptom checklists were excluded from an ADHD diagnosis after full assessment (Sibley et al., 2018). mind.io does not offer an ADHD test. If you suspect ADHD, get assessed by a psychiatrist. How to prepare for a first visit is covered in Seeing a psychiatrist for the first time.

Q. I can’t concentrate. Could it be ADHD? A. Depression, anxiety, sleep problems, thyroid problems and some medicines also affect concentration (WHO, 2024). If your mood is low or you worry a lot, the depression check-in (PHQ-9) or the anxiety check-in (GAD-7) is one place to start. Neither is a diagnosis either.

Q. Can ADHD start in adulthood? A. That question is not settled. The diagnostic criteria require symptoms before age 12 (WHO, 2024), and studies disagree about cases that seem to appear first in adulthood (Moffitt et al., 2015; Sibley et al., 2018).

Q. Does treatment help? A. Yes, some treatments reduce core symptoms in the short term (Ostinelli et al., 2025). Evidence on long-term effects is still thin and benefits for quality of life have not been shown, so plan treatment with a psychiatrist.

Q. It’s so hard I’m having thoughts of harming myself. A. Please do not carry them alone. Reach out to a crisis line right away: call or text 988 in the US and Canada, call Samaritans on 116 123 in the UK and Ireland, or find a line at findahelpline.com elsewhere. If you are in immediate danger, contact your local emergency services.

References: World Health Organization (2024), Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (CDDR), https://www.who.int/publications/i/item/9789240077263; National Institute of Mental Health (2024), ADHD in adults: 4 things to know, https://www.nimh.nih.gov/health/publications/adhd-what-you-need-to-know; National Center for Mental Health (2020), Adult ADHD [National Mental Health Information Portal, in Korean], https://www.mentalhealth.go.kr/portal/disease/diseaseDetail.do?dissId=15; National Institute for Health and Care Excellence (2018, updated 2019), Attention deficit hyperactivity disorder: diagnosis and management (NG87), https://www.nice.org.uk/guidance/ng87; Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., et al. (2021), The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder, Neuroscience & Biobehavioral Reviews 128, 789-818, https://doi.org/10.1016/j.neubiorev.2021.01.022; Beheshti, A., Chavanon, M.-L., & Christiansen, H. (2020), Emotion dysregulation in adults with attention deficit hyperactivity disorder: A meta-analysis, BMC Psychiatry 20(1), 120, https://doi.org/10.1186/s12888-020-2442-7; Lugo, J., Fadeuilhe, C., Gisbert, L., Setien, I., Delgado, M., Corrales, M., Richarte, V., & Ramos-Quiroga, J. A. (2020), Sleep in adults with autism spectrum disorder and attention deficit/hyperactivity disorder: A systematic review and meta-analysis, European Neuropsychopharmacology 38, 1-24, https://doi.org/10.1016/j.euroneuro.2020.07.004; Moffitt, T. E., Houts, R., Asherson, P., Belsky, D. W., Corcoran, D. L., Hammerle, M., et al. (2015), Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study, The American Journal of Psychiatry 172(10), 967-977, https://doi.org/10.1176/appi.ajp.2015.14101266; Sibley, M. H., Rohde, L. A., Swanson, J. M., Hechtman, L. T., Molina, B. S. G., Mitchell, J. T., et al. (2018), Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25, The American Journal of Psychiatry 175(2), 140-149, https://doi.org/10.1176/appi.ajp.2017.17030298; Fayyad, J., Sampson, N. A., Hwang, I., Adamowski, T., Aguilar-Gaxiola, S., et al. (2017), The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys, ADHD Attention Deficit and Hyperactivity Disorders 9(1), 47-65, https://doi.org/10.1007/s12402-016-0208-3; Song, P., Zha, M., Yang, Q., Zhang, Y., Li, X., Rudan, I., & Global Health Epidemiology Reference Group (2021), The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis, Journal of Global Health 11, 04009, https://doi.org/10.7189/jogh.11.04009; Faraone, S. V., Biederman, J., & Mick, E. (2006), The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies, Psychological Medicine 36(2), 159-165, https://doi.org/10.1017/S003329170500471X; Sibley, M. H., Arnold, L. E., Swanson, J. M., Hechtman, L. T., Kennedy, T. M., Owens, E., et al. (2022), Variable patterns of remission from ADHD in the Multimodal Treatment Study of ADHD, The American Journal of Psychiatry 179(2), 142-151, https://doi.org/10.1176/appi.ajp.2021.21010032; Health Insurance Review and Assessment Service (2026), Disease statistics: F90 hyperkinetic disorders, 2019-2025 [in Korean], https://opendata.hira.or.kr; Seo, J.-C., Jon, D.-I., Shim, S.-H., Sung, H.-M., Woo, Y. S., Hong, J., et al. (2022), Prevalence and comorbidities of attention deficit hyperactivity disorder among adults and children/adolescents in Korea, Clinical Psychopharmacology and Neuroscience 20(1), 126-134, https://doi.org/10.9758/cpn.2022.20.1.126 (corrigendum: https://doi.org/10.9758/cpn.2022.20.2.402); Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., et al. (2006), The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication, The American Journal of Psychiatry 163(4), 716-723, https://doi.org/10.1176/ajp.2006.163.4.716; Marcus, D. K., & Barry, T. D. (2011), Does attention-deficit/hyperactivity disorder have a dimensional latent structure? A taxometric analysis, Journal of Abnormal Psychology 120(2), 427-442, https://doi.org/10.1037/a0021405; Ra, C. K., Cho, J., Stone, M. D., De La Cerda, J., Goldenson, N. I., Moroney, E., et al. (2018), Association of digital media use with subsequent symptoms of attention-deficit/hyperactivity disorder among adolescents, JAMA 320(3), 255-263, https://doi.org/10.1001/jama.2018.8931; Yeung, A., Ng, E., & Abi-Jaoude, E. (2022), TikTok and attention-deficit/hyperactivity disorder: A cross-sectional study of social media content quality, The Canadian Journal of Psychiatry 67(12), 899-906, https://doi.org/10.1177/07067437221082854; Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., et al. (2005), The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population, Psychological Medicine 35(2), 245-256, https://doi.org/10.1017/S0033291704002892; Heo, S., Kim, J.-H., Joung, Y.-S., Lee, W.-I., Kim, J.-J., Sohn, S.-H., & Chang, S.-A. (2018), Clinical utility of the Korean version of the WHO adult attention-deficit/hyperactivity disorder self-report scale screener, Psychiatry Investigation 15(3), 325-329, https://doi.org/10.30773/pi.2017.07.10; Woo, Y. S., Hong, J. W., Shim, S.-H., Sung, H. M., Seo, J. S., Park, S.-Y., et al. (2023), Prevalence and comorbidities of adult attention-deficit/hyperactivity disorder in a community sample from Korea, Clinical Psychopharmacology and Neuroscience 21(4), 798-807, https://doi.org/10.9758/cpn.23.1112; Ostinelli, E. G., Schulze, M., Zangani, C., Farhat, L. C., Tomlinson, A., Del Giovane, C., et al. (2025), Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: A systematic review and component network meta-analysis, The Lancet Psychiatry 12(1), 32-43, https://doi.org/10.1016/S2215-0366(24)00360-2; Lopez, P. L., Torrente, F. M., Ciapponi, A., Lischinsky, A. G., Cetkovich-Bakmas, M., Rojas, J. I., et al. (2018), Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults, Cochrane Database of Systematic Reviews 2018(3), CD010840, https://doi.org/10.1002/14651858.CD010840.pub2.